---
title: "GROSS REMY — Ownership Dossier"
canonical: https://whiteintel.dev/entity/6340920f-7bf1-55ea-abb4-18726ac43de2
json: https://whiteintel.dev/api/public/dossier/6340920f-7bf1-55ea-abb4-18726ac43de2
identifier: sec:0002015973
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GROSS REMY

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0002015973`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/6340920f-7bf1-55ea-abb4-18726ac43de2  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/6340920f-7bf1-55ea-abb4-18726ac43de2  

## Ownership & control

### Holdings / subsidiaries

- **Serina Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/66f81ec4-86e1-5019-af9a-3108276a5ed1

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GROSS REMY**. Human view: https://whiteintel.dev/entity/6340920f-7bf1-55ea-abb4-18726ac43de2 · Structured JSON: https://whiteintel.dev/api/public/dossier/6340920f-7bf1-55ea-abb4-18726ac43de2._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._